Simultaneous CD8<sup>+</sup> T-Cell Immune Response against SARS-Cov-2 S, M, and N Induced by Endogenously Engineered Extracellular Vesicles in Both Spleen and Lungs
Most advanced vaccines against severe acute respiratory syndrome coronavirus (SARS-CoV)-2 are designed to induce antibodies against spike (S) protein. Differently, we developed an original strategy to induce CD8<sup>+</sup> T cytotoxic lymphocyte (CTL) immunity based on in vivo engineeri...
Main Authors: | Flavia Ferrantelli, Chiara Chiozzini, Francesco Manfredi, Andrea Giovannelli, Patrizia Leone, Maurizio Federico |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/9/3/240 |
Similar Items
-
N-Terminal Fatty Acids of NEF<sup>MUT</sup> Are Required for the CD8<sup>+</sup> T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
by: Chiara Chiozzini, et al.
Published: (2020-05-01) -
The C-Terminal Domain of Nef<sup>mut</sup> Is Dispensable for the CD8<sup>+</sup> T Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles
by: Chiara Chiozzini, et al.
Published: (2021-04-01) -
Long-Term Antitumor CD8<sup>+</sup> T Cell Immunity Induced by Endogenously Engineered Extracellular Vesicles
by: Flavia Ferrantelli, et al.
Published: (2021-05-01) -
Strong SARS-CoV-2 N-Specific CD8<sup>+</sup> T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
by: Flavia Ferrantelli, et al.
Published: (2022-02-01) -
Activation of Anti-SARS-CoV-2 Human CTLs by Extracellular Vesicles Engineered with the N Viral Protein
by: Francesco Manfredi, et al.
Published: (2022-06-01)